Focus Stocks

Facebook (FB)

Facebook (FB)


Apple (AAPL)

Apple (AAPL)


JP Morgan (JPM)

JP Morgan (JPM)


Yahoo (YHOO)

Yahoo (YHOO)


Microsoft (MSFT)

Microsoft (MSFT)


Featured Stories

Ventas Declares Regular Quarterly Dividend of {loadposition newstories}.62 Per Share

Ventas Declares Regular Quarterly Dividend of {loadposition newstories}.62 Per Share


Nucor To Acquire Skyline Steel LLC

Nucor To Acquire Skyline Steel LLC


Best ETFs For Facebook Exposure

Best ETFs For Facebook Exposure


Are the Bears Taking Control over F5 Networks?

Are the Bears Taking Control over F5 Networks?


Chico's FAS Reports First Quarter Earnings

Chico's FAS Reports First Quarter Earnings


Cepheid to Webcast Upcoming Financial Presentations


SUNNYVALE, Calif., Dec. 1, 2011 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.

Oppenheimer Healthcare Conference, New York, NY

Tuesday, December 13, 2011 at 10.50 a.m. Eastern Time

J.P. Morgan Healthcare Conference, San Francisco, CA

Thursday, January 12, 2012 at 10.30 a.m. Pacific Time

To access the live webcasts for these events, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcasts will be available shortly following the presentation and will remain available for at least 90 days.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.





CONTACTS:







For Media Inquiries:

For Investor Inquiries:





Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400-8377

This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

Jacquie Ross

Cepheid Investor Relations

Tel: (408) 400-8329

This e-mail address is being protected from spambots. You need JavaScript enabled to view it.











SOURCE Cepheid



Volatile market? That's when profit potential skyrockets for options traders. Now you can get up to 50 trade opportunities a week from top options experts -- plus much more -- on our exciting new site OptionsProfits. Try it FREE!

TradersHuddle Search

Sponsored By:

Stock Search:


Site Search:

Loading

Copyright © 2011 TradersHuddle.com. All Rights Reserved.